02659 BAO PHARMA-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 4.12X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 12.5% | Net Margin | N/A |
| Total Debt/Equity | 19.8% | Return on Equity | N/A |
| Price/Book | 18.91X | Return on Assets | N/A |
| (HKD 102.800) | 2025-12 | 2024-12 | 2023-12 |
| Net Profit (MHKD) | -440.01 | -387.57 | -176.79 |
|---|---|---|---|
| Net Profit Growth (%) | -13.5 | -119.2 | N/A |
| Earnings Per Share (HKD) | -1.516 | -1.448 | -3.494 |
| Earnings Per Share Growth (%) | -4.7 | +58.6 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 5.436 | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 49.156 | 6.16 | +698.0 | 6.93 |
| Operating Result | -395.072 | -363.723 | +8.6 | -159.452 |
| Associates | -0.238 | -0.609 | -60.9 | -0.915 |
| Profit Before Taxation | -395.302 | -364.41 | +8.5 | -160.394 |
| Taxation | 0 | 0.023 | -100.0 | 0.001 |
| Profit /( Loss) After Taxation | -395.302 | -364.433 | +8.5 | -160.395 |
| Net Profit | -395.302 | -364.433 | +8.5 | -160.395 |
| Earnings Per Share () | -1.5160 | -1.4479 | +4.7 | -3.4943 |
| Announcement Date | 2026-03-26 | 2025-12-02 | NA | 2025-12-02 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
